Does impaired gastric function cause vitamin B12 deficiency that presents with macrocytosis and elevated homocysteine?

The absorption of vitamin B12 is a complex, multi-stage process that begins in the stomach, where gastric function is critical for making dietary cobalamin bioavailable. Research confirms that impaired gastric and upper-GI function is a primary driver of deficiency, often manifesting through distinct hematologic and metabolic biomarkers.

Gastric mechanisms of B12 liberation

The stomach’s primary role in B12 absorption is the dissociation of the vitamin from dietary protein matrices.

• Acid-mediated release: Parietal cells secrete hydrochloric acid (HCl), lowering gastric pH to 1.5–3.5. This acidity is required to activate pepsinogen into pepsin, a proteolytic enzyme that hydrolyzes food proteins and releases bound B12.
• Protein dissociation: In cases of hypochlorhydria or achlorhydria (low or absent stomach acid), pepsin remains inactive, and the dietary protein-cobalamin bond remains intact. This prevents the release of free vitamin B12, leading to "food-cobalamin malabsorption," even if other parts of the absorption pathway are functional.
• Intracellular protection: Once released from food, B12 must bind to haptocorrin (R-protein) in the stomach to protect it from the acidic environment before it reaches the duodenum, where it eventually binds to intrinsic factor (IF) for absorption in the terminal ileum.

Clinical evidence of deficiency

Impaired gastric function, particularly atrophic gastritis (AG), is a major cause of vitamin B12 deficiency.

• Prevalence: Evidence from the TUDA study indicates that older adults with atrophic gastritis have a deficiency prevalence as high as 38%. In adults, autoimmune atrophic gastritis (pernicious anemia) accounts for 20% to 50% of B12 deficiency cases.
• Dual-pathway failure: AG causes deficiency through two mechanisms: the loss of gastric acid/pepsin (inhibiting food-B12 release) and the destruction of parietal cells, which reduces the production of intrinsic factor, essential for ileal absorption.
• Supplementation bypass: Clinical evidence shows that while these patients cannot absorb B12 from food, they can often absorb crystalline B12 (found in supplements) because it does not require acid-mediated protein dissociation.

Metabolic and hematologic markers

B12 deficiency disrupts critical biochemical pathways, leading to the presentation of macrocytosis and elevated homocysteine.

• Hyperhomocysteinemia: Vitamin B12 is a necessary cofactor for the enzyme methionine synthase, which converts homocysteine to methionine. Without sufficient B12, homocysteine accumulates; levels >15 μmol/L have a high diagnostic utility (AUC 0.78–0.79) for confirming deficiency.
• Macrocytosis (Megaloblastic Anemia): B12 is essential for DNA synthesis. Deficiency creates a "methyl-THF trap" that disrupts nucleotide production, leading to megaloblastic changes where cell nuclei mature slower than the cytoplasm. This results in macrocytosis (MCV >100 fL), which is observed in approximately 55% of adult B12 deficiency cases.
• Sensitivity considerations: While macrocytosis is a classic hallmark, it is an insensitive marker (sensitivity can be as low as 10% in early stages), and patients may present with neurological symptoms or elevated homocysteine before macrocytosis becomes evident.

Bottom line

Gastric acid and pepsin are physiologically mandatory for releasing vitamin B12 from food proteins. Impaired gastric function leads to B12 deficiency through malabsorption, which is clinically confirmed by elevated homocysteine (due to impaired methionine synthesis) and macrocytosis (due to disrupted DNA synthesis).